Apnimed, Inc. Common Stock

APMDNASDAQ • USD
18.99 USD
↗ 0.46 (2.48%)AT CLOSE (03:59 PM EDT)
19.09
↗ 0.10 (0.53%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
19.09
↗ 0.10 (0.53%)
🔴Market: CLOSED

Apnimed, Inc. Common Stock (APMD) trades at $18.99 per share. Technical indicators currently signal "Sell". This is driven by a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of Oct 23, 2026.

Open?$18.50
High?$19.15
Low?$17.84
Prev. Close?$18.53
Volume?269.4K
Avg. Volume?N/A
VWAP?$18.59
Bid / Ask
Bid?$17.68 × 500
Ask?$20.50 × 3.0K
Spread?$2.82
Midpoint?$19.09
Valuation & Ratios
Market Cap?790.6M
Shares Out?N/A
Float?17.9M
Float %?64.4%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).
Employees
N/A
Market Cap
790.6M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2026-07-31
Address
39 JOHN F. KENNEDY STREET, 4TH FLR.
CAMBRIDGE, MA 02138
Phone: 617-500-8880
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestElevated
Short % of Float?9.84%Elevated
Short Interest?1.8M
Days to Cover?2.1
Free Float17.9M
Avg Daily Volume843.1K
Settlement Date2026-09-30